Published in Cancer Weekly, October 11th, 2005
Under the collaboration, Invitrogen will use its expertise with the human proteome and proteomics-based approaches in combination with investigations by the lab of Sam Hanash, MD, PhD, at the Hutchinson Center.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.